These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 15991677)

  • 1. [New therapies for non-small cell lung cancer].
    Ostoros G; Kovács G; Szondy K; Döme B
    Orv Hetil; 2005 May; 146(21):1135-41. PubMed ID: 15991677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current management of advanced non-small cell lung cancer: targeted therapy.
    Isobe T; Herbst RS; Onn A
    Semin Oncol; 2005 Jun; 32(3):315-28. PubMed ID: 15988686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Targeted therapies and radiation therapy in non-small cell lung cancer].
    Rivera S; Quéro L; Wong Hee Kam S; Maylin C; Deutsch E; Hennequin C
    Cancer Radiother; 2011 Oct; 15(6-7):527-35. PubMed ID: 21885318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular targeted agents in non-small-cell lung cancer.
    Sandler AB
    Clin Lung Cancer; 2003 Sep; 5 Suppl 1():S22-8. PubMed ID: 14641991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase signal transduction inhibitors. Clinical trials.
    Scagliotti GV
    Suppl Tumori; 2002; 1(4):S34-6. PubMed ID: 12415814
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapy and new anticancer drugs in advanced disease.
    Silva S; Danson S
    Thorac Surg Clin; 2013 Aug; 23(3):411-9. PubMed ID: 23931023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy in non-small-cell lung cancer.
    Herbst RS
    Oncology (Williston Park); 2002 Sep; 16(9 Suppl 9):19-24. PubMed ID: 12375797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor inhibitors in the treatment of non-small-cell lung cancer.
    Giaccone G
    J Clin Oncol; 2005 May; 23(14):3235-42. PubMed ID: 15886311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies in the treatment of non small cell lung cancer: reality and hopes.
    Gridelli C
    Curr Opin Oncol; 2004 Mar; 16(2):126-9. PubMed ID: 15075903
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted therapy in advanced non-small cell lung cancer (NSCLC): where do we stand?
    Azim HA; Ganti AK
    Cancer Treat Rev; 2006 Dec; 32(8):630-6. PubMed ID: 17034953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in molecular-based personalized non-small-cell lung cancer therapy: targeting epidermal growth factor receptor and mechanisms of resistance.
    Jotte RM; Spigel DR
    Cancer Med; 2015 Nov; 4(11):1621-32. PubMed ID: 26310719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of targeted therapy in non-small cell lung cancer.
    Maione P; Rossi A; Airoma G; Ferrara C; Castaldo V; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):29-44. PubMed ID: 15207252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New advance of the molecular targeting agents in advanced non-small cell lung cancer].
    Zhang L; Cheng ZW; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):323-9. PubMed ID: 15266840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor tyrosine kinase inhibitors vs conventional chemotherapy in non-small cell lung cancer harboring wild-type epidermal growth factor receptor: a meta-analysis.
    Lee JK; Hahn S; Kim DW; Suh KJ; Keam B; Kim TM; Lee SH; Heo DS
    JAMA; 2014 Apr; 311(14):1430-7. PubMed ID: 24715074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of switching to a second EGFR-TKI after a severe AE related to a first EGFR-TKI in EGFR-mutated NSCLC.
    Takeda M; Okamoto I; Tsurutani J; Oiso N; Kawada A; Nakagawa K
    Jpn J Clin Oncol; 2012 Jun; 42(6):528-33. PubMed ID: 22457323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor as a target to improve treatment of lung cancer.
    Andratschke NH; Dittmann KH; Mason KA; Fan Z; Liao Z; Komaki R; Ang KK; Milas L
    Clin Lung Cancer; 2004 May; 5(6):340-52. PubMed ID: 15217533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
    Raben D; Helfrich B; Bunn PA
    Int J Radiat Oncol Biol Phys; 2004; 59(2 Suppl):27-38. PubMed ID: 15142632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological agents in non-small cell lung cancer: a review of recent advances and clinical results with a focus on epidermal growth factor receptor and vascular endothelial growth factor.
    Kelly K; Huang C
    J Thorac Oncol; 2008 Jun; 3(6):664-73. PubMed ID: 18520811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of epidermal growth factor receptor/HER2 inhibitors in the treatment of patients with non-small-cell lung cancer.
    Govindan R
    Clin Lung Cancer; 2010 Jan; 11(1):8-12. PubMed ID: 20085861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.